STEWARTVILLE, Minn.,
March 30, 2011 /PRNewswire/ --
Rochester Medical Corporation (Nasdaq: ROCM) announced that the
shareholders of Fornix BioSciences N.V. today approved the
previously announced sale of Laprolan B.V. its Medical Supplies
Division and wholly owned subsidiary to Rochester Medical
Corporation.
Rochester Medical expects the transaction to close in the near
term, and under the terms of the Share Purchase Agreement between
Rochester Medical and Fornix, be deemed retroactive to January 1, 2011. For more information
regarding this transaction please refer to the Company's
January 12, 2011 press release.
This press release contains "forward-looking statements" with
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, but are not limited to,
statements about the expected completion of the acquisition of
Laprolan. Such statements are based on currently available
information, operating plans and management's expectations about
future events and trends. Such statements inherently involve
significant risks and uncertainties that could cause actual results
to differ materially from those predicted in such forward-looking
statements, including the risk factors listed from time to time in
the Company's SEC reports and filings, including, without
limitation, the section entitled "Risk Factors" in the Company's
Annual Report on Form 10-K for the year ended September 30, 2010. Readers are cautioned
not to place undue reliance on any such forward-looking statements,
which speak only as of the date they are made. The Company
undertakes no obligation to update any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Rochester Medical Corporation develops, manufactures, and
markets latex-free disposable medical catheters and devices for
urological and continence care applications. The Company
markets under its own Rochester Medical® brand and under existing
private label arrangements.
For further information, please contact Anthony J. Conway, President and Chief Executive
Officer or David A. Jonas, Chief
Financial Officer of Rochester Medical Corporation at (507)
533-9600. More information about Rochester Medical is
available on its website at http://www.rocm.com.
SOURCE Rochester Medical Corporation